Facebook PixelBioSynapse - Pathways To Life Sciences Innovation
For Biomedical Professionals

BIOSYNAPSE

Pathways To Life Sciences Innovation

Ask anything on topics in biomedical research

We provide accurate answers based only on trustworthy documents - millions of peer-reviewed full-length research articles, MSD Veterinary Manual*, and FDA databases

MSD Logo

*MSD Veterinary Manual is licensed under an agreement with MSD & Co, Inc. and all rights are reserved by Copyright ©2025 MSD & Co., Inc., Rahway, New Jersey, USA and its affiliates.

4,000,000+
Full-text Papers
3+
Data Sources
100%
Reference-based Answers
Daily
Data Updates

BioSynapse is a specialized AI chatbot service that provides 100% reference-based answers to biomedical researchers, powered by over 4 million full-text papers, FDA databases, and the MSD Veterinary Manual.

Unlike ChatGPT, every answer includes PMID/DOI citations, providing only verified information without hallucinations.

Under The Hood

Autonomous Research Agent

BioSynapse goes beyond simple search. Our reasoning engine deconstructs your questions, validates sources, and synthesizes evidence through a rigorous 3-step pipeline.

Query Decomposition

Complex clinical questions are broken into logical units, with medical context mapped to optimal search strategies.

Multi-Source Retrieval

Real-time literature collection from PubMed and specialized databases, filtered by Impact Factor and recency.

Evidence Synthesis

Collected evidence is synthesized into answers with sentence-level citations mapped to original sources.

Verified Knowledge Base

Hallucination-Free,
Reference-Backed.

Experts demand verified facts, not plausible-sounding responses. Every BioSynapse answer links directly to peer-reviewed literature and clinical guidelines. One click to verify the source.

PMID / DOI Integration
Precise literature tracking via international standard identifiers
Real-time Updates
Daily updates with the latest published research

...A recent Phase 3 clinical trial demonstrated a 24% risk reduction compared to placebo (SOURCE 1).

New England Journal of Medicine PMID: 38123456

Efficacy and Safety of Novel Therapeutic Agents in Cardiovascular Outcomes

J. Doe et al. 2024 Jan 15

"In this multicenter, double-blind, randomized trial, we assigned patients... resulted in a significantly lower risk of death from cardiovascular causes..."

FAQ

Frequently asked questions

01 What kind of service is BioSynapse?

BioSynapse is an AI-based service that provides literature-based information needed by researchers in the biomedical field. It helps researchers find and utilize biomedical-related papers and information more quickly and efficiently.

02 What fields of information does BioSynapse provide?

We provide information across the entire spectrum of biomedical research fields, including molecular biology, genomics, proteomics, cell biology, immunology, neuroscience, and pharmacology.

03 Is the service difficult to use?

No, you can simply ask questions as if you're chatting. It's optimized for mobile, so you can easily use it on your smartphone as well.

04 How is BioSynapse different from ChatGPT or Elicit?

ChatGPT is based on training data with potential hallucination issues, and Elicit specializes in paper search but uses limited data. BioSynapse integrates 4M+ full-text papers with MSD and FDA data, providing 100% reference-based answers with PMID/DOI citations for every response.